Arvinas (ARVN) Operating Income (2017 - 2026)

Arvinas (ARVN) recorded quarterly Operating Income of -$63.8 million in Q1 2026, up 14.48% quarter-over-quarter from -$74.6 million in Q4 2025, and down 189.36% on a YoY basis from $71.4 million in Q1 2025.

Arvinas (ARVN) Operating Income (2017 - 2026) Analysis & Trends

Arvinas' Operating Income history runs 10 years deep, the most recent figure standing at -$63.8 million for Q1 2026.

  • In Q1 2026, Operating Income fell 189.36% year-over-year to -$63.8 million; the TTM figure through Mar 2026 stood at -$253.7 million (down 165.38% YoY), while the FY2025 annual figure was -$118.5 million, up 52.64% from the prior year.
  • Operating Income was -$63.8 million for Q1 2026 at Arvinas, up from -$74.6 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $71.4 million in Q1 2025 to a low of -$165.3 million in Q4 2023.
  • Historically, Operating Income has averaged -$64.6 million across 5 years, with a median of -$65.8 million in 2022.
  • The sharpest annual moves came in 2025 and 2026: Operating Income surged 185.71% in 2025, then slumped 189.36% in 2026.
  • A 5-year view of Operating Income shows it stood at -$75.6 million in 2022, then plunged by 118.65% to -$165.3 million in 2023, then soared by 64.79% to -$58.2 million in 2024, then decreased by 28.18% to -$74.6 million in 2025, then advanced by 14.48% to -$63.8 million in 2026.
  • The last three Operating Income figures came in at -$63.8 million (Q1 2026), -$74.6 million (Q4 2025), and -$43.8 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -32.68 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -2.97 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -19.70 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -3.82 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -15.76 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 1.14 Bn
9 Abivax 91.96 Bn 91.96 Bn - -65.83 Mn
10 Arvinas 492.16 Mn -122.74 Mn - -63.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -63.80 Mn
Dec 31, 2025 -74.60 Mn
Sep 30, 2025 -43.80 Mn
Jun 30, 2025 -71.50 Mn
Mar 31, 2025 71.40 Mn
Dec 31, 2024 -58.20 Mn
Sep 30, 2024 -60.30 Mn
Jun 30, 2024 -48.50 Mn
Mar 31, 2024 -83.30 Mn
Dec 31, 2023 -165.30 Mn
Sep 30, 2023 -73.90 Mn
Jun 30, 2023 -74.60 Mn
Mar 31, 2023 -87.70 Mn
Dec 31, 2022 -75.60 Mn
Sep 30, 2022 -64.30 Mn
Jun 30, 2022 -65.80 Mn
Mar 31, 2022 -57.70 Mn
Dec 31, 2021 -47.50 Mn
Sep 30, 2021 -47.30 Mn
Jun 30, 2021 -51.90 Mn